3-iodobenzylguanidine has been researched along with Carcinoma, Transitional Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, M; Brown, M; Carruthers, R; Fullerton, NE; Keith, WN; Kirk, D; Mairs, RJ; McCluskey, AG; Wilson, L | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.
Topics: 3-Iodobenzylguanidine; Carcinoma, Transitional Cell; Cell Line, Tumor; Genetic Therapy; Humans; Iodine Radioisotopes; Norepinephrine Plasma Membrane Transport Proteins; Radiotherapy; Symporters; Telomerase; Urinary Bladder Neoplasms | 2005 |